Today

Agents

Chat

Arena

Discover

More

App

CytoSorbents Q3 revenue USD 9.728 million - CTSO News | Rallies

CytoSorbents Q3 revenue USD 9.728 million

CTSO•2026-11-12

CytoSorbents reported Q3 revenue of USD 9.728 million, EPS of USD -0.58 and a gross margin of 75%.

1. Q3 results

CytoSorbents reported Q3 revenue of USD 9.728 million, EPS of USD -0.58 and a gross margin of 75%.

Related News

Cisco lifts annual revenue forecast on strong AI networking demand

CSCO•2026-11-12

Indian travel agency Yatra Online's Q2 revenue falls on lower MICE business

YTRA•2026-11-12

Caliber Q3 2026 net loss attributable to company widens 15% year over year to $5.03 million

Sources

S

CytoSorbents Q3 2026 net loss narrows 42% to $1.8 million; revenue rises to $9.7 million

Sec

CWD

•

2026-11-12

Transcontinental Realty Q3 revenue rises but swings to net loss on higher operating expenses

TCI•2026-11-12

Stantec Q3 adjusted EPS CAD 1.89 vs. IBES estimate CAD 1.78

STN•2026-11-12